Commission Regulation (EU) 2018/781 of 29 May 2018 amending Regulation (EC) No 847/2000 as regards the definition of the concept ‘similar medicinal product’
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XIII Medicinal Products
Joint committee decision (JCD)
238/2018 In force in the EEA
Yes Legal documents
Commission Regulation (EU) 2018/781 of 29 May 2018 amending Regulation (EC) No 847/2000 as regards the definition of the concept ‘similar medicinal product’
Reglugerð framkvæmdastjórnarinnar (ESB) 2018/781 frá 29. maí 2018 um breytingu á reglugerð (EB) nr. 847/2000 að því er varðar skilgreiningu á hugtakinu „samsvarandi lyf“
Verordnung (EU) 2018/781 der Kommission vom 29. Mai 2018 zur Änderung der Verordnung (EG) Nr. 847/2000 in Bezug auf die Bestimmung des Begriffs „ähnliches Arzneimittel“
Kommisjonsforordning (EU) 2018/781 av 29. mai 2018 om endring av forordning (EF) nr. 847/2000 med hensyn til definisjonen av uttrykket «lignende legemiddel»
History
06.12.2018
Adopted JCD confirmed entry into force date
06.12.2018
Compliance date in the EEA
05.12.2018
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
01.10.2018
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
29.05.2018
Adoption date in the EU
19.06.2018
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.